Elizabeth Jackson Blankenship
CIK: 0002115811
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NHI
NATIONAL HEALTH INVESTORS INC
Officer
Discretionary Trading P&L
Holdings
About Blankenship Elizabeth Jackson
Blankenship Elizabeth Jackson (SEC CIK 0002115811) files insider reports with the SEC as SVP, Legal Affairs of NATIONAL HEALTH INVESTORS INC (NHI).
Signal8 holds 3 ownership filings by Blankenship Elizabeth Jackson (2 Form 3, 1 Form 4), filed between Mar 4, 2026 and Mar 30, 2026. Those filings report 1 transaction, the latest on Mar 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Blankenship Elizabeth Jackson's filings is in MURFREESBORO, TN.
Recent filings by Blankenship Elizabeth Jackson
- Mar 3, 2026: Grant or award of NHI shares (Form 4, code A).
Other insiders filing for NATIONAL HEALTH INVESTORS INC (NHI)
- Maingot Christian Ken, Chief Operating Officer
- Siefert Todd Michael, Chief Financial Officer
- MCCABE ROBERT A JR, Director
- Jobe James R, Director
- Mendelsohn D. Eric, CEO and President
- Spaid John L, CFO/EVP Finance